Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Corbus Pharmaceuticals ( (CRBP) ) has shared an announcement.
On March 20, 2025, Dr. Peter Salzmann informed Corbus Pharmaceuticals Holdings, Inc. that he will not seek re-election to the Board of Directors at the 2025 annual meeting. Dr. Salzmann will continue his role until the meeting, and his decision was not due to any disagreements with the company. Consequently, the Board will reduce its size from eight to seven members after the meeting.
More about Corbus Pharmaceuticals
YTD Price Performance: -49.92%
Average Trading Volume: 239,202
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $77.43M
See more data about CRBP stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue